by Vandana Singh | Apr 9, 2026 | General
Eli Lilly and Co. (NYSE:LLY) on Wednesday announced that Foundayo (orforglipron) is now available to adults with obesity or overweight with weight-related medical problems. Access Expands Across LillyDirect, Telehealth And Retail Pharmacies Last week, the U.S. Food...
by Henry Khederian | Apr 9, 2026 | General
Robinhood Markets Inc (NASDAQ:HOOD) shares are trading lower Thursday morning after fresh U.S. economic data painted a more fragile backdrop for the consumer and for market risk appetite, a setup that can matter directly for retail-trading platforms like Robinhood....
by Benzinga Insights | Apr 9, 2026 | General
NVIDIA (NASDAQ:NVDA) has outperformed the market over the past 5 years by 53.07% on an annualized basis producing an average annual return of 63.43%. Currently, NVIDIA has a market capitalization of $4.44 trillion. Buying $1000 In NVDA: If an investor had bought $1000...
by Benzinga Insights | Apr 9, 2026 | General
Global X Artificial Intelligence & Technology ETF (NASDAQ:AIQ) has outperformed the market over the past 10 years by 8.93% on an annualized basis producing an average annual return of 21.43%. Currently, Global X Artificial Intelligence & Technology ETF has a...
by Vandana Singh | Apr 9, 2026 | General
Replimune Group (NASDAQ:REPL) shares are down on Thursday. The company faces an upcoming FDA review decision on Friday, 10 April. Replimmune RP1 Filing Faces Regulatory Hurdles In October 2025, the U.S. Food and Drug Administration (FDA) accepted the resubmission of...
Recent Comments